glp 1 non injection The Rise of the GLP-1s: Beyond Diabetes and Obesity GLP-1 Medications for Weight Loss

I have to say after a little bit of an adjustment period you can really feel this stuff working

Host-microbe-drug-nutrient screen identifies bacterial effectors of metformin therapy

This risk was reduced even further in cases of prolonged treatment extending beyond three years (HR: 0.71), though GLP-1RA treatment for zero to one years (HR: 0.89) and one to three years (HR: 0.85) were not significant

"There are now effective drugs, and this could lead to higher labor productivity, gains in longevity, and potentially reduce medical costs costs elsewhere in the health system." Columbia Threadneedle Investments reported that the weight-loss drug industry could become a $1.7 trillion annual market if 100 million Americans took GLP-1s at their current price

doi: 10.1111/dom.12963

The semaglutide versus tirzepatide comparison further contextualizes where semaglutide sits in the overall hierarchy